
LINK . SPRINGER . COM {
}
Title:
TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol | Trials
Description:
Background We present a study protocol for a randomized, double-blind, placebo-controlled trial that investigates the hypothesis if intervention in the symptomatic phase preceding clinical arthritis (clinically suspect arthralgia (CSA)) is effective in preventing progression from subclinical inflammation to clinically apparent persistent arthritis. Currently, rheumatoid arthritis (RA) can be recognized and diagnosed when arthritis (joint swelling) has become detectable at physical examination. Importantly, at this time, the immune processes have already matured, chronicity is established, and patients require long-standing treatment with disease-modifying anti-rheumatic drugs. The TREAT EARLIER trial studies the hypothesis that intervention in the symptomatic phase preceding clinical arthritis is more often successful in permanent disease modification because of less matured underlying disease processes. Methods A two-level definition to identify patients that are prone to develop RA is used. First, patients should have CSA and recent-onset arthralgia (< 1 year) that is suspect to progress to RA according to the expertise of the treating rheumatologist. Second, patients need to have subclinical inflammation of the hand or foot joints at 1.5 T MRI. The trial aims to recruit 230 participants from secondary care hospital settings across the south-west region of The Netherlands. Intervention will be randomly assigned and includes a single-dose of intramuscular 120 mg methylprednisolon followed by methotrexate (increasing dose to 25 mg/week orally) or placebo (both; injection and tablets) over the course of 1 year. Thereafter, participants are followed for another year. The primary endpoint is the development of clinically detectable arthritis, either fulfilling the 2010 criteria for RA or unclassified clinical arthritis of ≥ 2 joints, which persists for at least 2 weeks. DMARD-free status is a co-primary endpoint. The patient-reported outcomes functioning, along with workability and symptoms, are key secondary endpoints. Participants, caregivers (including those assessing the endpoints), and scientific staff are all blinded to the group assignment. Discussion This proof-of-concept study is the logical consequence of pre-work on the identification of patients with CSA with MRI-detected subclinical joint inflammation. It will test the hypothesis whether intervention in patients in this early phase with the cornerstone treatment of classified RA (methotrexate) hampers the development of persistent RA and reduce the disease burden of RA. Trial registration Dutch Trial Register NL4599 (NTR4853). Registered on 20 October 2014
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Health & Fitness
- Education
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't tell how the site generates income.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
arthritis, trial, patients, study, participants, data, article, mri, clinical, pubmed, google, scholar, rheumatoid, van, csa, mtx, inflammation, endpoint, rheumatology, arthralgia, primary, disease, protocol, treatment, rheum, subclinical, clinically, joints, ann, dis, department, lumc, phase, joint, netherlands, months, time, rheumatologists, results, participant, followup, early, development, risk, years, medical, cas, symptoms, mil, intervention,
Topics {✒️}
nl/richtlijnen/nvr-richtlijnen-standpunten-en-zorgpaden/ org/standaarden/volledig/nhg-standaard-artritis disease-modifying anti-rheumatic drugs van der horst-bruinsma steroidal anti-inflammatory drugs anti-citrullinated peptide antibody placebo-controlled trials aiming age-matched symptom-free persons anti-carbamylated protein antibodies van steenbergen hw article download pdf van nies ja joint/bone/tendon sheath level van der kooij placebo-controlled intervention study multiple joints/bones/tendon sheaths open-label dmard therapy participant open-ended questions randomized placebo-controlled mri-detected subclinical inflammation acute bone stress symptomatic pre-arthritis phase maturing auto-antibody response imaging-detected subclinical inflammation rheumatism eq-5d-5l acute-phase reactants achieve secondary prevention age-matched general population van de laar placebo-controlled trial received concomitant medication disease-modifying drugs bmc musculoskelet disord c-reactive protein van baarsen lg van dijk bt van gaalen fa gillet-van dongen ra-specific inflammation starts shared decision-making healthcare central committee achieved dmard-free status privacy choices/manage cookies ten brinck rm cyclic citrullinated peptide longitudinal leiden-csa cohort checking medical forms informed written consent—randomization clinically apparent arthritis open access reported
Questions {❓}
- Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
- Is anti-citrullinated protein antibody-positive rheumatoid arthritis still a more severe disease than anti-citrullinated protein antibody-negative rheumatoid arthritis?
- Rheumatoid arthritis prevention in arthralgia: fantasy or reality?
- The earlier, the better or the worse?
- What is the prevalence of MRI-detected inflammation and erosions in small joints in the general population?
- Which patients presenting with arthralgia eventually develop rheumatoid arthritis?
- Who will take informed consent?
Schema {🗺️}
WebPage:
mainEntity:
headline:TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol
description:We present a study protocol for a randomized, double-blind, placebo-controlled trial that investigates the hypothesis if intervention in the symptomatic phase preceding clinical arthritis (clinically suspect arthralgia (CSA)) is effective in preventing progression from subclinical inflammation to clinically apparent persistent arthritis. Currently, rheumatoid arthritis (RA) can be recognized and diagnosed when arthritis (joint swelling) has become detectable at physical examination. Importantly, at this time, the immune processes have already matured, chronicity is established, and patients require long-standing treatment with disease-modifying anti-rheumatic drugs. The TREAT EARLIER trial studies the hypothesis that intervention in the symptomatic phase preceding clinical arthritis is more often successful in permanent disease modification because of less matured underlying disease processes. A two-level definition to identify patients that are prone to develop RA is used. First, patients should have CSA and recent-onset arthralgia (< 1 year) that is suspect to progress to RA according to the expertise of the treating rheumatologist. Second, patients need to have subclinical inflammation of the hand or foot joints at 1.5 T MRI. The trial aims to recruit 230 participants from secondary care hospital settings across the south-west region of The Netherlands. Intervention will be randomly assigned and includes a single-dose of intramuscular 120 mg methylprednisolon followed by methotrexate (increasing dose to 25 mg/week orally) or placebo (both; injection and tablets) over the course of 1 year. Thereafter, participants are followed for another year. The primary endpoint is the development of clinically detectable arthritis, either fulfilling the 2010 criteria for RA or unclassified clinical arthritis of ≥ 2 joints, which persists for at least 2 weeks. DMARD-free status is a co-primary endpoint. The patient-reported outcomes functioning, along with workability and symptoms, are key secondary endpoints. Participants, caregivers (including those assessing the endpoints), and scientific staff are all blinded to the group assignment. This proof-of-concept study is the logical consequence of pre-work on the identification of patients with CSA with MRI-detected subclinical joint inflammation. It will test the hypothesis whether intervention in patients in this early phase with the cornerstone treatment of classified RA (methotrexate) hampers the development of persistent RA and reduce the disease burden of RA. Dutch Trial Register
NL4599
(NTR4853). Registered on 20 October 2014
datePublished:2020-10-16T00:00:00Z
dateModified:2020-10-16T00:00:00Z
pageStart:1
pageEnd:18
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13063-020-04731-2
keywords:
Rheumatoid arthritis
Clinically suspect arthralgia
Subclinical inflammation
MRI
Intervention
Prevention
Methotrexate
Double-blind
Placebo-controlled
Randomized
Medicine/Public Health
general
Biomedicine
Statistics for Life Sciences
Medicine
Health Sciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig4_HTML.png
isPartOf:
name:Trials
issn:
1745-6215
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ellis Niemantsverdriet
url:http://orcid.org/0000-0002-5781-3817
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Yousra J. Dakkak
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Leonie E. Burgers
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Femke Bonte-Mineur
affiliation:
name:Maasstad Hospital
address:
name:Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Gerda M. Steup-Beekman
affiliation:
name:Haaglanden Medical Center – Bronovo
address:
name:Department of Rheumatology, Haaglanden Medical Center – Bronovo, The Hague, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Sjoerd M. van der Kooij
affiliation:
name:Haga Hospital
address:
name:Department of Rheumatology, Haga Hospital, The Hague, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Hido D. Boom
affiliation:
name:Spaarne Gasthuis
address:
name:Department of Rheumatology, Spaarne Gasthuis, Haarlem, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Cornelia F. Allaart
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Pascal H. P. de Jong
affiliation:
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Annette H. M. van der Helm-van Mil
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol
description:We present a study protocol for a randomized, double-blind, placebo-controlled trial that investigates the hypothesis if intervention in the symptomatic phase preceding clinical arthritis (clinically suspect arthralgia (CSA)) is effective in preventing progression from subclinical inflammation to clinically apparent persistent arthritis. Currently, rheumatoid arthritis (RA) can be recognized and diagnosed when arthritis (joint swelling) has become detectable at physical examination. Importantly, at this time, the immune processes have already matured, chronicity is established, and patients require long-standing treatment with disease-modifying anti-rheumatic drugs. The TREAT EARLIER trial studies the hypothesis that intervention in the symptomatic phase preceding clinical arthritis is more often successful in permanent disease modification because of less matured underlying disease processes. A two-level definition to identify patients that are prone to develop RA is used. First, patients should have CSA and recent-onset arthralgia (< 1 year) that is suspect to progress to RA according to the expertise of the treating rheumatologist. Second, patients need to have subclinical inflammation of the hand or foot joints at 1.5 T MRI. The trial aims to recruit 230 participants from secondary care hospital settings across the south-west region of The Netherlands. Intervention will be randomly assigned and includes a single-dose of intramuscular 120 mg methylprednisolon followed by methotrexate (increasing dose to 25 mg/week orally) or placebo (both; injection and tablets) over the course of 1 year. Thereafter, participants are followed for another year. The primary endpoint is the development of clinically detectable arthritis, either fulfilling the 2010 criteria for RA or unclassified clinical arthritis of ≥ 2 joints, which persists for at least 2 weeks. DMARD-free status is a co-primary endpoint. The patient-reported outcomes functioning, along with workability and symptoms, are key secondary endpoints. Participants, caregivers (including those assessing the endpoints), and scientific staff are all blinded to the group assignment. This proof-of-concept study is the logical consequence of pre-work on the identification of patients with CSA with MRI-detected subclinical joint inflammation. It will test the hypothesis whether intervention in patients in this early phase with the cornerstone treatment of classified RA (methotrexate) hampers the development of persistent RA and reduce the disease burden of RA. Dutch Trial Register
NL4599
(NTR4853). Registered on 20 October 2014
datePublished:2020-10-16T00:00:00Z
dateModified:2020-10-16T00:00:00Z
pageStart:1
pageEnd:18
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13063-020-04731-2
keywords:
Rheumatoid arthritis
Clinically suspect arthralgia
Subclinical inflammation
MRI
Intervention
Prevention
Methotrexate
Double-blind
Placebo-controlled
Randomized
Medicine/Public Health
general
Biomedicine
Statistics for Life Sciences
Medicine
Health Sciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_Fig4_HTML.png
isPartOf:
name:Trials
issn:
1745-6215
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ellis Niemantsverdriet
url:http://orcid.org/0000-0002-5781-3817
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Yousra J. Dakkak
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Leonie E. Burgers
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Femke Bonte-Mineur
affiliation:
name:Maasstad Hospital
address:
name:Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Gerda M. Steup-Beekman
affiliation:
name:Haaglanden Medical Center – Bronovo
address:
name:Department of Rheumatology, Haaglanden Medical Center – Bronovo, The Hague, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Sjoerd M. van der Kooij
affiliation:
name:Haga Hospital
address:
name:Department of Rheumatology, Haga Hospital, The Hague, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Hido D. Boom
affiliation:
name:Spaarne Gasthuis
address:
name:Department of Rheumatology, Spaarne Gasthuis, Haarlem, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Cornelia F. Allaart
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Pascal H. P. de Jong
affiliation:
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Annette H. M. van der Helm-van Mil
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Trials
issn:
1745-6215
volumeNumber:21
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
name:Maasstad Hospital
address:
name:Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands
type:PostalAddress
name:Haaglanden Medical Center – Bronovo
address:
name:Department of Rheumatology, Haaglanden Medical Center – Bronovo, The Hague, The Netherlands
type:PostalAddress
name:Haga Hospital
address:
name:Department of Rheumatology, Haga Hospital, The Hague, The Netherlands
type:PostalAddress
name:Spaarne Gasthuis
address:
name:Department of Rheumatology, Spaarne Gasthuis, Haarlem, The Netherlands
type:PostalAddress
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Ellis Niemantsverdriet
url:http://orcid.org/0000-0002-5781-3817
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
name:Yousra J. Dakkak
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
name:Leonie E. Burgers
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
name:Femke Bonte-Mineur
affiliation:
name:Maasstad Hospital
address:
name:Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
name:Gerda M. Steup-Beekman
affiliation:
name:Haaglanden Medical Center – Bronovo
address:
name:Department of Rheumatology, Haaglanden Medical Center – Bronovo, The Hague, The Netherlands
type:PostalAddress
type:Organization
name:Sjoerd M. van der Kooij
affiliation:
name:Haga Hospital
address:
name:Department of Rheumatology, Haga Hospital, The Hague, The Netherlands
type:PostalAddress
type:Organization
name:Hido D. Boom
affiliation:
name:Spaarne Gasthuis
address:
name:Department of Rheumatology, Spaarne Gasthuis, Haarlem, The Netherlands
type:PostalAddress
type:Organization
name:Cornelia F. Allaart
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
name:Pascal H. P. de Jong
affiliation:
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
name:Annette H. M. van der Helm-van Mil
affiliation:
name:Leiden University Medical Center
address:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
type:PostalAddress
type:Organization
name:Erasmus Medical Center
address:
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
name:Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands
name:Department of Rheumatology, Haaglanden Medical Center – Bronovo, The Hague, The Netherlands
name:Department of Rheumatology, Haga Hospital, The Hague, The Netherlands
name:Department of Rheumatology, Spaarne Gasthuis, Haarlem, The Netherlands
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
name:Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
name:Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands
External Links {🔗}(214)
- How much income does https://www.springernature.com/gp/authors have?
- What's the profit of https://link.springernature.com/home/?
- How much does https://order.springer.com/public/cart earn?
- How much money does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research make?
- What is the monthly revenue of https://trialsjournal.biomedcentral.com/about?
- What's the income of https://www.editorialmanager.com/trls/?
- Explore the financials of https://orcid.org/0000-0002-5781-3817
- Check the income stats for https://www.trialregister.nl/trial/4599
- What's the profit of http://www.clinicaltrialsregister.eu?
- How much does http://www.clinicaltrials.gov pull in?
- Explore the financials of https://www.nhg.org/standaarden/volledig/nhg-standaard-artritis
- Learn about the earnings of https://www.nvr.nl/richtlijnen/nvr-richtlijnen-standpunten-en-zorgpaden/
- What's the financial outcome of https://doi.org/10.1136%2Frmdopen-2014-000041?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26509063 making per month?
- What are the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612698?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Fatigue%20in%20rheumatoid%20arthritis%3B%20a%20persistent%20problem%3A%20a%20large%20longitudinal%20study&journal=RMD%20Open&doi=10.1136%2Frmdopen-2014-000041&volume=1&issue=1&publication_year=2015&author=Steenbergen%2CHW&author=Tsonaka%2CR&author=Huizinga%2CTW&author=Boonen%2CA&author=Mil%2CAH?
- How much income is https://doi.org/10.1002%2Facr.23305 earning monthly?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Determinants%20of%20perceived%20health%20nonimprovement%20in%20early%20rheumatoid%20arthritis%20patients%20with%20favorable%20treatment%20outcomes&journal=Arthritis%20Care%20Res%20%28Hoboken%29&doi=10.1002%2Facr.23305&volume=70&issue=4&pages=510-515&publication_year=2018&author=Steunebrink%2CLMM&author=Oude%20Voshaar%2CMAH&author=Taal%2CE&author=Vonkeman%2CHE&author=Zijlstra%2CTR&author=Laar%2CM
- What's the revenue for https://doi.org/10.1136%2Fannrheumdis-2012-202911?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23520035?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Predictors%20of%20work%20disability%20during%20the%20first%203%20years%20after%20diagnosis%20in%20a%20national%20rheumatoid%20arthritis%20inception%20cohort&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2012-202911&volume=73&issue=5&pages=845-853&publication_year=2014&author=Olofsson%2CT&author=Petersson%2CIF&author=Eriksson%2CJK&author=Englund%2CM&author=Simard%2CJF&author=Nilsson%2CJA
- How much does https://doi.org/10.1136%2Fannrheumdis-2013-204080 bring in each month?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24323395?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Costs%20for%20hospital%20care%2C%20drugs%20and%20lost%20work%20days%20in%20incident%20and%20prevalent%20rheumatoid%20arthritis%3A%20how%20large%2C%20and%20how%20are%20they%20distributed%3F&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2013-204080&volume=74&issue=4&pages=648-654&publication_year=2015&author=Eriksson%2CJK&author=Johansson%2CK&author=Askling%2CJ&author=Neovius%2CM
- https://doi.org/10.1136%2Fannrheumdis-2011-200990 income
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22387728?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=EULAR%20recommendations%20for%20terminology%20and%20research%20in%20individuals%20at%20risk%20of%20rheumatoid%20arthritis%3A%20report%20from%20the%20Study%20Group%20for%20Risk%20Factors%20for%20Rheumatoid%20Arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2011-200990&volume=71&issue=5&pages=638-641&publication_year=2012&author=Gerlag%2CDM&author=Raza%2CK&author=Baarsen%2CLG&author=Brouwer%2CE&author=Buckley%2CCD&author=Burmester%2CGR
- How much revenue does https://doi.org/10.1016%2Fj.clinthera.2019.04.013 produce monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31196657 bring in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Nomenclature%20for%20the%20phases%20of%20the%20development%20of%20rheumatoid%20arthritis&journal=Clin%20Ther&doi=10.1016%2Fj.clinthera.2019.04.013&volume=41&issue=7&pages=1279-1285&publication_year=2019&author=Raza%2CK&author=Holers%2CVM&author=Gerlag%2CD make?
- What's https://doi.org/10.1136%2Fannrheumdis-2016-209846's gross income?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27991858
- How much does http://scholar.google.com/scholar_lookup?&title=EULAR%20definition%20of%20arthralgia%20suspicious%20for%20progression%20to%20rheumatoid%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2016-209846&volume=76&issue=3&pages=491-496&publication_year=2017&author=Steenbergen%2CHW&author=Aletaha%2CD&author=Beaart-van%20de%20Voorde%2CLJ&author=Brouwer%2CE&author=Codreanu%2CC&author=Combe%2CB generate monthly?
- How much revenue does https://doi.org/10.1093%2Frheumatology%2Fkev431 bring in?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Clinical%20expertise%20and%20its%20accuracy%20in%20differentiating%20arthralgia%20patients%20at%20risk%20for%20rheumatoid%20arthritis%20from%20other%20patients%20presenting%20with%20joint%20symptoms&journal=Rheumatology%20%28Oxford%2C%20England%29&doi=10.1093%2Frheumatology%2Fkev431&volume=55&issue=6&pages=1140-1141&publication_year=2016&author=Steenbergen%2CHW&author=Mil%2CAH?
- Learn about the earnings of https://doi.org/10.1136%2Frmdopen-2016-000419
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28879045 income
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574454 is on a monthly basis
- Income figures for http://scholar.google.com/scholar_lookup?&title=Functional%20limitations%20in%20the%20phase%20of%20clinically%20suspect%20arthralgia%20are%20as%20serious%20as%20in%20early%20clinical%20arthritis%3B%20a%20longitudinal%20study&journal=RMD%20Open&doi=10.1136%2Frmdopen-2016-000419&volume=3&issue=1&publication_year=2017&author=Brinck%2CRM&author=Steenbergen%2CHW&author=Mangnus%2CL&author=Burgers%2CLE&author=Reijnierse%2CM&author=Huizinga%2CTW
- How much money does https://doi.org/10.1002%2Fart.11223 make?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14558078?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Antibodies%20against%20cyclic%20citrullinated%20peptide%20and%20IgA%20rheumatoid%20factor%20predict%20the%20development%20of%20rheumatoid%20arthritis&journal=Arthritis%20Rheum&doi=10.1002%2Fart.11223&volume=48&issue=10&pages=2741-2749&publication_year=2003&author=Rantapaa-Dahlqvist%2CS&author=Jong%2CBA&author=Berglin%2CE&author=Hallmans%2CG&author=Wadell%2CG&author=Stenlund%2CH?
- Earnings of https://doi.org/10.1002%2Fart.20018
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14872479?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Specific%20autoantibodies%20precede%20the%20symptoms%20of%20rheumatoid%20arthritis%3A%20a%20study%20of%20serial%20measurements%20in%20blood%20donors&journal=Arthritis%20Rheum&doi=10.1002%2Fart.20018&volume=50&issue=2&pages=380-386&publication_year=2004&author=Nielen%2CMM&author=Schaardenburg%2CD&author=Reesink%2CHW&author=Stadt%2CRJ&author=Horst-Bruinsma%2CIE&author=Koning%2CMH?
- https://doi.org/10.1093%2Frheumatology%2Fkex235's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Using%20a%20reference%20when%20defining%20an%20abnormal%20MRI%20reduces%20false-positive%20MRI%20results-a%20longitudinal%20study%20in%20two%20cohorts%20at%20risk%20for%20rheumatoid%20arthritis&journal=Rheumatology%20%28Oxford%2C%20England%29&doi=10.1093%2Frheumatology%2Fkex235&volume=56&issue=10&pages=1700-1706&publication_year=2017&author=Boer%2CAC&author=Burgers%2CLE&author=Mangnus%2CL&author=Brinck%2CRM&author=Nieuwenhuis%2CWP&author=Steenbergen%2CHW bring in each month?
- Revenue of https://doi.org/10.1136%2Frmdopen-2014-000005
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26509042 make?
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613156 make?
- What's the income of http://scholar.google.com/scholar_lookup?&title=What%20is%20the%20prevalence%20of%20MRI-detected%20inflammation%20and%20erosions%20in%20small%20joints%20in%20the%20general%20population%3F%20A%20collation%20and%20analysis%20of%20published%20data&journal=RMD%20Open&doi=10.1136%2Frmdopen-2014-000005&volume=1&issue=1&publication_year=2015&author=Mangnus%2CL&author=Schoones%2CJW&author=Mil%2CAH?
- https://doi.org/10.1136%2Fannrheumdis-2015-208138 income
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26613769?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Clinical%20factors%2C%20anticitrullinated%20peptide%20antibodies%20and%20MRI-detected%20subclinical%20inflammation%20in%20relation%20to%20progression%20from%20clinically%20suspect%20arthralgia%20to%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2015-208138&volume=75&issue=10&pages=1824-1830&publication_year=2016&author=Steenbergen%2CHW&author=Mangnus%2CL&author=Reijnierse%2CM&author=Huizinga%2CTW&author=Mil%2CAH
- https://doi.org/10.1038%2Fnrrheum.2017.185 income
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29118439
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Preventing%20progression%20from%20arthralgia%20to%20arthritis%3A%20targeting%20the%20right%20patients&journal=Nat%20Rev%20Rheumatol&doi=10.1038%2Fnrrheum.2017.185&volume=14&issue=1&pages=32-41&publication_year=2018&author=Steenbergen%2CHW&author=Silva%2CJAP&author=Huizinga%2CTWJ&author=Mil%2CAHM?
- https://doi.org/10.1136%2Frmdopen-2017-000479's revenue stream
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29177078?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687532 gross monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Which%20patients%20presenting%20with%20arthralgia%20eventually%20develop%20rheumatoid%20arthritis%3F%20The%20current%20state%20of%20the%20art&journal=RMD%20Open&doi=10.1136%2Frmdopen-2017-000479&volume=3&issue=2&publication_year=2017&author=Boeters%2CDM&author=Raza%2CK&author=Vander%20Helm-van%20Mil%2CAHM generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31771618 produce monthly?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880566 income
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20search%20to%20the%20target%20tissue%20in%20which%20RA-specific%20inflammation%20starts%3A%20a%20detailed%20MRI%20study%20to%20improve%20identification%20of%20RA-specific%20features%20in%20the%20phase%20of%20clinically%20suspect%20arthralgia&journal=Arthritis%20Res%20Ther&doi=10.1186%2Fs13075-019-2002-z&volume=21&issue=1&publication_year=2019&author=Matthijssen%2CXME&author=Wouters%2CF&author=Boeters%2CDM&author=Boer%2CAC&author=Dakkak%2CYJ&author=Niemantsverdriet%2CE generate?
- Financial intake of https://doi.org/10.1136%2Fannrheumdis-2019-216137
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Obtaining%20high%20positive%20predictive%20values%20for%20the%20development%20of%20clinically%20apparent%20arthritis%20in%20patients%20presenting%20with%20clinically%20suspect%20arthralgia%3B%20is%20it%20feasible%3F&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2019-216137&volume=79&publication_year=2020&author=Matthijssen%2CXME&author=Dijk%2CBT&author=Wouters%2CF&author=Niemantsverdriet%2CE&author=Mil%2CAHM
- https://doi.org/10.1002%2Facr.23497's revenue stream
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Is%20anti-citrullinated%20protein%20antibody-positive%20rheumatoid%20arthritis%20still%20a%20more%20severe%20disease%20than%20anti-citrullinated%20protein%20antibody-negative%20rheumatoid%20arthritis%3F%20A%20longitudinal%20cohort%20study%20in%20rheumatoid%20arthritis%20patients%20diagnosed%20from%202000%20onward&journal=Arthritis%20Care%20Res%20%28Hoboken%29&doi=10.1002%2Facr.23497&volume=70&issue=7&pages=987-996&publication_year=2018&author=Boer%2CAC&author=Boonen%2CA&author=Mil%2CAHM?
- What is the monthly revenue of https://doi.org/10.1136%2Fannrheumdis-2016-210602?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27979873 earn?
- Income figures for http://scholar.google.com/scholar_lookup?&title=2016%20update%20of%20the%20EULAR%20recommendations%20for%20the%20management%20of%20early%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2016-210602&volume=76&issue=6&pages=948-959&publication_year=2017&author=Combe%2CB&author=Landewe%2CR&author=Daien%2CCI&author=Hua%2CC&author=Aletaha%2CD&author=Alvaro-Gracia%2CJM
- https://doi.org/10.1136%2Frmdopen-2018-000870 income
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31168406 produce monthly?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525606?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Window%20of%20opportunity%20in%20rheumatoid%20arthritis%20-%20definitions%20and%20supporting%20evidence%3A%20from%20old%20to%20new%20perspectives&journal=RMD%20Open&doi=10.1136%2Frmdopen-2018-000870&volume=5&issue=1&publication_year=2019&author=Burgers%2CLE&author=Raza%2CK&author=Mil%2CAH bring in?
- How profitable is https://doi.org/10.1002%2Fart.27584?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20872595's revenue stream
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=2010%20rheumatoid%20arthritis%20classification%20criteria%3A%20an%20American%20College%20of%20Rheumatology%2FEuropean%20League%20Against%20Rheumatism%20collaborative%20initiative&journal=Arthritis%20Rheum&doi=10.1002%2Fart.27584&volume=62&issue=9&pages=2569-2581&publication_year=2010&author=Aletaha%2CD&author=Neogi%2CT&author=Silman%2CAJ&author=Funovits%2CJ&author=Felson%2CDT&author=Bingham%2CCO?
- What is the monthly revenue of https://doi.org/10.1136%2Fannrheumdis-2013-204573?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24161836
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=EULAR%20recommendations%20for%20the%20management%20of%20rheumatoid%20arthritis%20with%20synthetic%20and%20biological%20disease-modifying%20antirheumatic%20drugs%3A%202013%20update&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2013-204573&volume=73&issue=3&pages=492-509&publication_year=2014&author=Smolen%2CJS&author=Landewe%2CR&author=Breedveld%2CFC&author=Buch%2CM&author=Burmester%2CG&author=Dougados%2CM?
- How much does https://doi.org/10.1136%2Fannrheumdis-2012-202289 net monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22952388
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Improved%20early%20identification%20of%20arthritis%3A%20evaluating%20the%20efficacy%20of%20Early%20Arthritis%20Recognition%20Clinics&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2012-202289&volume=72&issue=8&pages=1295-1301&publication_year=2013&author=Nies%2CJA&author=Brouwer%2CE&author=Gaalen%2CFA&author=Allaart%2CCF&author=Huizinga%2CTW&author=Posthumus%2CMD bring in?
- How much profit does https://doi.org/10.1136%2Fannrheumdis-2014-205522 make?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24718962's total income per month
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Characterising%20arthralgia%20in%20the%20preclinical%20phase%20of%20rheumatoid%20arthritis%20using%20MRI&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2014-205522&volume=74&issue=6&pages=1225-1232&publication_year=2015&author=Steenbergen%2CHW&author=Nies%2CJA&author=Huizinga%2CTW&author=Bloem%2CJL&author=Reijnierse%2CM&author=Mil%2CAH?
- What's the monthly income of https://doi.org/10.1093%2Frheumatology%2Fkex324?
- How much income does http://scholar.google.com/scholar_lookup?&title=Validation%20of%20the%20EULAR%20definition%20of%20arthralgia%20suspicious%20for%20progression%20to%20rheumatoid%20arthritis&journal=Rheumatology%20%28Oxford%2C%20England%29&doi=10.1093%2Frheumatology%2Fkex324&volume=56&issue=12&pages=2123-2128&publication_year=2017&author=Burgers%2CLE&author=Siljehult%2CF&author=Brinck%2CRM&author=Steenbergen%2CHW&author=Landewe%2CRBM&author=Rantapaa-Dahlqvist%2CS have?
- How much profit is https://doi.org/10.1136%2Fard.2004.031773 making per month?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15647420
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766828 income
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=An%20introduction%20to%20the%20EULAR-OMERACT%20rheumatoid%20arthritis%20MRI%20reference%20image%20atlas&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2004.031773&volume=64&issue=Suppl%201&pages=i3-i7&publication_year=2005&author=Ostergaard%2CM&author=Edmonds%2CJ&author=McQueen%2CF&author=Peterfy%2CC&author=Lassere%2CM&author=Ejbjerg%2CB?
- https://doi.org/10.1136%2Fard.2006.068361's total income per month
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17392347 make?
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1955157?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Introduction%20of%20a%20novel%20magnetic%20resonance%20imaging%20tenosynovitis%20score%20for%20rheumatoid%20arthritis%3A%20reliability%20in%20a%20multireader%20longitudinal%20study&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2006.068361&volume=66&issue=9&pages=1216-1220&publication_year=2007&author=Haavardsholm%2CEA&author=Ostergaard%2CM&author=Ejbjerg%2CBJ&author=Kvan%2CNP&author=Kvien%2CTK?
- Get to know https://doi.org/10.5271%2Fsjweh.2690's earnings
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=397615?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Peritendinitis%20and%20tenosynovitis.%20A%20review&journal=Scand%20J%20Work%20Environ%20Health&doi=10.5271%2Fsjweh.2690&volume=5&issue=suppl%203&pages=19-24&publication_year=1979&author=Kurppa%2CK&author=Waris%2CP&author=Rokkanen%2CP bring in?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Surgical%20anatomy%20of%20the%20hand%20and%20upper%20extremity&publication_year=2003&author=Doyle%2CJR&author=Botte%2CMJ
- What's the monthly money flow for https://doi.org/10.1136%2Fard.2007.076463?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17934080 generate?
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2111621 earns monthly
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Optimal%20use%20of%20methotrexate%3A%20the%20advantages%20of%20tight%20control&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2007.076463&volume=66&issue=11&pages=1409-1410&publication_year=2007&author=Bijlsma%2CJW&author=Weinblatt%2CME?
- How much does https://doi.org/10.1136%2Fannrheumdis-2017-211268 earn?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28866645
- How much income does http://scholar.google.com/scholar_lookup?&title=Optimal%20methotrexate%20dose%20is%20associated%20with%20better%20clinical%20outcomes%20than%20non-optimal%20dose%20in%20daily%20practice%3A%20results%20from%20the%20ESPOIR%20early%20arthritis%20cohort&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2017-211268&volume=76&issue=12&pages=2054-2060&publication_year=2017&author=Gaujoux-Viala%2CC&author=Rincheval%2CN&author=Dougados%2CM&author=Combe%2CB&author=Fautrel%2CB have?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31969328?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=EULAR%20recommendations%20for%20the%20management%20of%20rheumatoid%20arthritis%20with%20synthetic%20and%20biological%20disease-modifying%20antirheumatic%20drugs%3A%202019%20update&journal=Ann%20Rheum%20Dis&volume=79&issue=6&pages=685-699&publication_year=2020&author=Smolen%2CJS&author=Landewe%2CRBM&author=Bijlsma%2CJWJ&author=Burmester%2CGR&author=Dougados%2CM&author=Kerschbaumer%2CA?
- What's the monthly money flow for https://doi.org/10.1136%2Fannrheumdis-2014-205228?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24728329 each month?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Head-to-head%2C%20randomised%2C%20crossover%20study%20of%20oral%20versus%20subcutaneous%20methotrexate%20in%20patients%20with%20rheumatoid%20arthritis%3A%20drug-exposure%20limitations%20of%20oral%20methotrexate%20at%20doses%20%E2%89%A515%20mg%20may%20be%20overcome%20with%20subcutaneous%20administration&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2014-205228&volume=73&issue=8&pages=1549-1551&publication_year=2014&author=Schiff%2CMH&author=Jaffe%2CJS&author=Freundlich%2CB?
- What's the monthly income of https://doi.org/10.1136%2Fard.2009.122473?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20223838 make?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=The%20Stop%20Arthritis%20Very%20Early%20%28SAVE%29%20trial%2C%20an%20international%20multicentre%2C%20randomised%2C%20double-blind%2C%20placebo-controlled%20trial%20on%20glucocorticoids%20in%20very%20early%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2009.122473&volume=69&issue=3&pages=495-502&publication_year=2010&author=Machold%2CKP&author=Landewe%2CR&author=Smolen%2CJS&author=Stamm%2CTA&author=Heijde%2CDM&author=Verpoort%2CKN
- How much profit does https://doi.org/10.1136%2Fard.2009.119149 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19825849 generate?
- See how much http://scholar.google.com/scholar_lookup?&title=Beneficial%20effects%20of%20a%203-week%20course%20of%20intramuscular%20glucocorticoid%20injections%20in%20patients%20with%20very%20early%20inflammatory%20polyarthritis%3A%20results%20of%20the%20STIVEA%20trial&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2009.119149&volume=69&issue=3&pages=503-509&publication_year=2010&author=Verstappen%2CSM&author=McCoy%2CMJ&author=Roberts%2CC&author=Dale%2CNE&author=Hassell%2CAB&author=Symmons%2CDP makes per month
- How much income does https://doi.org/10.1136%2Fannrheumdis-2011-201162 have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22679301 earn?
- How much does http://scholar.google.com/scholar_lookup?&title=Induction%20therapy%20with%20a%20combination%20of%20DMARDs%20is%20better%20than%20methotrexate%20monotherapy%3A%20first%20results%20of%20the%20tREACH%20trial&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2011-201162&volume=72&issue=1&pages=72-78&publication_year=2013&author=Jong%2CPH&author=Hazes%2CJM&author=Barendregt%2CPJ&author=Huisman%2CM&author=Zeben%2CD&author=Lubbe%2CPA generate monthly?
- How much cash flow does https://doi.org/10.1136%2Fannrheumdis-2013-204588 have monthly?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24395555?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20conventional%20synthetic%20disease-modifying%20antirheumatic%20drugs%2C%20glucocorticoids%20and%20tofacitinib%3A%20a%20systematic%20literature%20review%20informing%20the%202013%20update%20of%20the%20EULAR%20recommendations%20for%20management%20of%20rheumatoid%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2013-204588&volume=73&issue=3&pages=510-515&publication_year=2014&author=Gaujoux-Viala%2CC&author=Nam%2CJ&author=Ramiro%2CS&author=Landewe%2CR&author=Buch%2CMH&author=Smolen%2CJS earns monthly
- What's https://doi.org/10.1136%2Fannrheumdis-2019-216537's gross income?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32033935?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Effect%20on%20efficacy%20and%20safety%20trial%20outcomes%20of%20also%20enrolling%20patients%20on%20ongoing%20glucocorticoid%20therapy%20in%20rheumatoid%20arthritis%20clinical%20trials%20of%20tocilizumab%20or%20adalimumab%20or%20methotrexate%20monotherapy&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2019-216537&volume=79&issue=4&pages=460-463&publication_year=2020&author=Safy-Khan%2CM&author=Jacobs%2CJWG&author=Hair%2CMJH&author=Welsing%2CPMJ&author=Edwardes%2CMD&author=Teitsma%2CXM have monthly?
- What's the revenue for https://doi.org/10.1093%2Frheumatology%2Fkel100?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Acetaminophen%2C%20like%20conventional%20NSAIDs%2C%20may%20reduce%20synovitis%20in%20osteoarthritic%20knees&journal=Rheumatology%20%28Oxford%2C%20England%29&doi=10.1093%2Frheumatology%2Fkel100&volume=45&issue=11&pages=1389-1394&publication_year=2006&author=Brandt%2CKD&author=Mazzuca%2CSA&author=Buckwalter%2CKA?
- How much profit does https://doi.org/10.3899%2Fjrheum.181064 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30770509 pull in?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Validity%20and%20responsiveness%20of%20combined%20inflammation%20and%20combined%20joint%20damage%20scores%20based%20on%20the%20OMERACT%20Rheumatoid%20Arthritis%20MRI%20Scoring%20System%20%28RAMRIS%29&journal=J%20Rheumatol&doi=10.3899%2Fjrheum.181064&volume=46&issue=9&pages=1222-1227&publication_year=2019&author=Sundin%2CU&author=Ostergaard%2CM&author=Glinatsi%2CD&author=Aga%2CAB&author=Horslev-Petersen%2CK&author=Hetland%2CML making per month?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25073253
- How much does http://scholar.google.com/scholar_lookup?&title=MR%20imaging%20of%20the%20knee%20at%203T--diagnostic%20performance%20and%20comparison%20with%201.5T&journal=JBR-BTR&volume=97&issue=2&pages=126-127&publication_year=2014&author=Dyck%2CP rake in every month?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21645348?
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121660
- How much does http://scholar.google.com/scholar_lookup?&title=Comparison%20of%201.5T%20and%203T%20MRI%20scanners%20in%20evaluation%20of%20acute%20bone%20stress%20in%20the%20foot&journal=BMC%20Musculoskelet%20Disord&doi=10.1186%2F1471-2474-12-128&volume=12&publication_year=2011&author=Sormaala%2CMJ&author=Ruohola%2CJP&author=Mattila%2CVM&author=Koskinen%2CSK&author=Pihlajamaki%2CHK pull in?
- How much does https://doi.org/10.1093%2Frheumatology%2Fkeu029 make?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Bone%20marrow%20oedema%20assessment%20by%20magnetic%20resonance%20imaging%20in%20rheumatoid%20arthritis%20wrist%20and%20metacarpophalangeal%20joints%3A%20the%20importance%20of%20field%20strength%2C%20coil%20type%20and%20image%20resolution&journal=Rheumatology%20%28Oxford%2C%20England%29&doi=10.1093%2Frheumatology%2Fkeu029&volume=53&issue=8&pages=1446-1451&publication_year=2014&author=Krabbe%2CS&author=Eshed%2CI&author=Pedersen%2CSJ&author=Boyesen%2CP&author=Moller%2CJM&author=Therkildsen%2CF
- Check the income stats for https://doi.org/10.1002%2Fjmri.24668
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24912802 earning monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=In%20vitro%20assessment%20of%20knee%20MRI%20in%20the%20presence%20of%20metal%20implants%20comparing%20MAVRIC-SL%20and%20conventional%20fast%20spin%20echo%20sequences%20at%201.5%20and%203%20T%20field%20strength&journal=J%20Magn%20Reson%20Imaging&doi=10.1002%2Fjmri.24668&volume=41&issue=5&pages=1291-1299&publication_year=2015&author=Liebl%2CH&author=Heilmeier%2CU&author=Lee%2CS&author=Nardo%2CL&author=Patsch%2CJ&author=Schuppert%2CC's earnings
- Profit of https://doi.org/10.1136%2Frmdopen-2018-000728
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29955387?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018882 make?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=MR%20signal%20intensity%3A%20staying%20on%20the%20bright%20side%20in%20MR%20image%20interpretation&journal=RMD%20Open&doi=10.1136%2Frmdopen-2018-000728&volume=4&issue=1&publication_year=2018&author=Bloem%2CJL&author=Reijnierse%2CM&author=Huizinga%2CTWJ&author=Mil%2CAHM?
- Find out how much https://doi.org/10.1038%2Fnrrheum.2016.175 earns monthly
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27784891
- Profit of http://scholar.google.com/scholar_lookup?&title=Mechanism%20of%20action%20of%20methotrexate%20in%20rheumatoid%20arthritis%2C%20and%20the%20search%20for%20biomarkers&journal=Nat%20Rev%20Rheumatol&doi=10.1038%2Fnrrheum.2016.175&volume=12&issue=12&pages=731-742&publication_year=2016&author=Brown%2CPM&author=Pratt%2CAG&author=Isaacs%2CJD
- What's the income generated by https://doi.org/10.1136%2Fannrheumdis-2012-202967 each month?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23334213
- Income figures for http://scholar.google.com/scholar_lookup?&title=Five-year%20outcomes%20of%20probable%20rheumatoid%20arthritis%20treated%20with%20methotrexate%20or%20placebo%20during%20the%20first%20year%20%28the%20PROMPT%20study%29&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2012-202967&volume=73&issue=2&pages=396-400&publication_year=2014&author=Aken%2CJ&author=Heimans%2CL&author=Gillet-van%20Dongen%2CH&author=Visser%2CK&author=Ronday%2CHK&author=Speyer%2CI
- Check the income stats for https://doi.org/10.1136%2Fannrheumdis-2019-216716
- How much does http://scholar.google.com/scholar_lookup?&title=The%20earlier%2C%20the%20better%20or%20the%20worse%3F%20Towards%20accurate%20management%20of%20patients%20with%20arthralgia%20at%20risk%20for%20RA&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2019-216716&volume=79&issue=3&pages=312-315&publication_year=2020&author=Mil%2CA&author=Landewe%2CRBM bring in each month?
- How much money does https://doi.org/10.1136%2Fannrheumdis-2016-209835 generate?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27903508
- Profit of http://scholar.google.com/scholar_lookup?&title=The%20patient%20perspective%20on%20absence%20of%20disease%20activity%20in%20rheumatoid%20arthritis%3A%20a%20survey%20to%20identify%20key%20domains%20of%20patient-perceived%20remission&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2016-209835&volume=76&issue=5&pages=855-861&publication_year=2017&author=Tuyl%2CLH&author=Sadlonova%2CM&author=Hewlett%2CS&author=Davis%2CB&author=Flurey%2CC&author=Goel%2CN
- How much does https://doi.org/10.1136%2Fard.2009.126821 pull in?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21156761?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=A%20genome-wide%20association%20study%20suggests%20contrasting%20associations%20in%20ACPA-positive%20versus%20ACPA-negative%20rheumatoid%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2009.126821&volume=70&issue=2&pages=259-265&publication_year=2011&author=Padyukov%2CL&author=Seielstad%2CM&author=Ong%2CRT&author=Ding%2CB&author=Ronnelid%2CJ&author=Seddighzadeh%2CM?
- How much profit does https://doi.org/10.1016%2Fj.berh.2017.08.003 generate?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29221595's gross income?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726551 net monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Genetic%20and%20environmental%20risk%20factors%20for%20rheumatoid%20arthritis&journal=Best%20Pract%20Res%20Clin%20Rheumatol&doi=10.1016%2Fj.berh.2017.08.003&volume=31&issue=1&pages=3-18&publication_year=2017&author=Deane%2CKD&author=Demoruelle%2CMK&author=Kelmenson%2CLB&author=Kuhn%2CKA&author=Norris%2CJM&author=Holers%2CVM
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16872514?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779386 make?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Environmental%20risk%20factors%20differ%20between%20rheumatoid%20arthritis%20with%20and%20without%20auto-antibodies%20against%20cyclic%20citrullinated%20peptides&journal=Arthritis%20Res%20Ther&doi=10.1186%2Far2022&volume=8&issue=4&publication_year=2006&author=Pedersen%2CM&author=Jacobsen%2CS&author=Klarlund%2CM&author=Pedersen%2CBV&author=Wiik%2CA&author=Wohlfahrt%2CJ each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Antibodies%20to%20citrullinated%20proteins%20and%20differences%20in%20clinical%20progression%20of%20rheumatoid%20arthritis&journal=Arthritis%20Res%20Ther&doi=10.1186%2Far1767&volume=7&issue=5&pages=R949-R958&publication_year=2005&author=Mil%2CAH&author=Verpoort%2CKN&author=Breedveld%2CFC&author=Toes%2CRE&author=Huizinga%2CTW produce monthly?
- See how much https://doi.org/10.1136%2Fannrheumdis-2017-211325 makes per month
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28606964?
- http://scholar.google.com/scholar_lookup?&title=Differences%20in%20the%20symptomatic%20phase%20preceding%20ACPA-positive%20and%20ACPA-negative%20RA%3A%20a%20longitudinal%20study%20in%20arthralgia%20during%20progression%20to%20clinical%20arthritis&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2017-211325&volume=76&issue=10&pages=1751-1754&publication_year=2017&author=Burgers%2CLE&author=Steenbergen%2CHW&author=Brinck%2CRM&author=Huizinga%2CTW&author=Mil%2CAH's financial summary
- What is the monthly revenue of https://citation-needed.springer.com/v2/references/10.1186/s13063-020-04731-2?format=refman&flavour=references?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ellis%20Niemantsverdriet?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ellis%20Niemantsverdriet%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yousra%20J.%20Dakkak?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yousra%20J.%20Dakkak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Leonie%20E.%20Burgers have monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Leonie%20E.%20Burgers%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Femke%20Bonte-Mineur?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Femke%20Bonte-Mineur%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gerda%20M.%20Steup-Beekman generate monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gerda%20M.%20Steup-Beekman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sjoerd%20M.%20van%20der%20Kooij bring in each month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sjoerd%20M.%20van%20der%20Kooij%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hido%20D.%20Boom gross monthly?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hido%20D.%20Boom%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cornelia%20F.%20Allaart
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cornelia%20F.%20Allaart%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Pascal%20H.%20P.%20de%20Jong
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Pascal%20H.%20P.%20de%20Jong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Annette%20H.%20M.%20van%20der%20Helm-van%20Mil have?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Annette%20H.%20M.%20van%20der%20Helm-van%20Mil%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- Learn about the earnings of https://static-content.springer.com/esm/art%3A10.1186%2Fs13063-020-04731-2/MediaObjects/13063_2020_4731_MOESM1_ESM.docx
- Profit of http://creativecommons.org/licenses/by/4.0/
- What's the monthly income of http://creativecommons.org/publicdomain/zero/1.0/?
- How much does https://s100.copyright.com/AppDispatchServlet?title=TREAT%20Early%20Arthralgia%20to%20Reverse%20or%20Limit%20Impending%20Exacerbation%20to%20Rheumatoid%20arthritis%20%28TREAT%20EARLIER%29%3A%20a%20randomized%2C%20double-blind%2C%20placebo-controlled%20clinical%20trial%20protocol&author=Ellis%20Niemantsverdriet%20et%20al&contentID=10.1186%2Fs13063-020-04731-2©right=The%20Author%28s%29&publication=1745-6215&publicationDate=2020-10-16&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 earn?
- Revenue of https://crossmark.crossref.org/dialog/?doi=10.1186/s13063-020-04731-2
- https://citation-needed.springer.com/v2/references/10.1186/s13063-020-04731-2?format=refman&flavour=citation's financial summary
- What are the total earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- What's the financial gain of https://www.springernature.com/gp/products?
- Earnings of https://www.springernature.com/gp/librarians
- Learn how profitable https://www.springernature.com/gp/societies is on a monthly basis
- What's the total monthly financial gain of https://www.springernature.com/gp/partners?
- What is the earnings of https://www.springer.com/?
- https://www.nature.com/'s revenue stream
- What's the income of https://www.biomedcentral.com/?
- Check the income stats for https://www.palgrave.com/
- How much profit does https://www.apress.com/ generate?
- How much profit does https://www.springernature.com/gp/legal/ccpa make?
- How much does https://www.springernature.com/gp/info/accessibility net monthly?
- What are the earnings of https://support.springernature.com/en/support/home?
- Financial intake of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- Financial intake of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref